These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22300718)

  • 1. The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda.
    Anderson EJ; Webb EL; Mawa PA; Kizza M; Lyadda N; Nampijja M; Elliott AM
    Vaccine; 2012 Mar; 30(12):2083-9. PubMed ID: 22300718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.
    Lule SA; Mawa PA; Nkurunungi G; Nampijja M; Kizito D; Akello F; Muhangi L; Elliott AM; Webb EL
    Vaccine; 2015 Feb; 33(6):796-804. PubMed ID: 25529292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Latent
    Lubyayi L; Mawa PA; Nabakooza G; Nakibuule M; Tushabe JV; Serubanja J; Aibo D; Akurut H; Tumusiime J; Hasso-Agopsowicz M; Kaleebu P; Levin J; Dockrell HM; Smith S; Webb EL; Elliott AM; Cose S
    Front Immunol; 2020; 11():929. PubMed ID: 32477371
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of
    Mawa PA; Hasso-Agopsowicz M; Lubyayi L; Nabakooza G; Nakibuule M; Blitz R; Dun L; Govind A; Kaleebu P; Webb EL; Elliott AM; Dockrell HM; Cose S; Smith SG
    Front Immunol; 2021; 12():637114. PubMed ID: 33815390
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.
    Finan C; Ota MO; Marchant A; Newport MJ
    PLoS One; 2008; 3(10):e3485. PubMed ID: 18941532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.
    Kiravu A; Osawe S; Happel AU; Nundalall T; Wendoh J; Beer S; Dontsa N; Alinde OB; Mohammed S; Datong P; Cameron DW; Rosenthal K; Abimiku A; Jaspan HB; Gray CM
    Front Immunol; 2019; 10():2307. PubMed ID: 31649662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
    Smith SG; Zelmer A; Blitz R; Fletcher HA; Dockrell HM
    Vaccine; 2016 Oct; 34(44):5298-5305. PubMed ID: 27622301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal BCG scar is associated with increased infant proinflammatory immune responses.
    Mawa PA; Webb EL; Filali-Mouhim A; Nkurunungi G; Sekaly RP; Lule SA; Prentice S; Nash S; Dockrell HM; Elliott AM; Cose S
    Vaccine; 2017 Jan; 35(2):273-282. PubMed ID: 27914741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.
    Wu B; Huang C; Garcia L; Ponce de Leon A; Osornio JS; Bobadilla-del-Valle M; Ferreira L; Canizales S; Small P; Kato-Maeda M; Krensky AM; Clayberger C
    Infect Immun; 2007 Jul; 75(7):3658-64. PubMed ID: 17502394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation.
    Elliott AM; Mawa PA; Webb EL; Nampijja M; Lyadda N; Bukusuba J; Kizza M; Namujju PB; Nabulime J; Ndibazza J; Muwanga M; Whitworth JA
    Vaccine; 2010 Dec; 29(2):247-55. PubMed ID: 21040693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A
    Pittet LF; Fritschi N; Tebruegge M; Dutta B; Donath S; Messina NL; Casalaz D; Hanekom WA; Britton WJ; Robins-Browne R; Curtis N; Ritz N
    Am J Respir Crit Care Med; 2022 Apr; 205(7):830-841. PubMed ID: 35007188
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447].
    Elliott AM; Namujju PB; Mawa PA; Quigley MA; Nampijja M; Nkurunziza PM; Belisle JT; Muwanga M; Whitworth JA;
    BMC Infect Dis; 2005 Dec; 5():115. PubMed ID: 16371154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing cytokine production and clinical response following vaccination with BCG Moreau and BCG Russia strains in a Brazilian infant population.
    Bitencourt J; Sarno A; Oliveira C; Souza RA; Lima CC; Takenami I; Pereira SM; Arruda S
    Vaccine; 2021 May; 39(23):3189-3196. PubMed ID: 33965255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological effect of revaccination with Bacille Calmette-Guérin vaccine at 19 months of age.
    Andersen A; Roth A; Jensen KJ; Erikstrup C; Lisse IM; Whittle H; Sartono E; Yazdanbakhsh M; Aaby P; Benn CS
    Vaccine; 2013 Apr; 31(17):2137-44. PubMed ID: 23474315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
    Fletcher HA; Tanner R; Wallis RS; Meyer J; Manjaly ZR; Harris S; Satti I; Silver RF; Hoft D; Kampmann B; Walker KB; Dockrell HM; Fruth U; Barker L; Brennan MJ; McShane H
    Clin Vaccine Immunol; 2013 Nov; 20(11):1683-9. PubMed ID: 23986316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.
    Hasan Z; Jamil B; Ashraf M; Islam M; Dojki M; Irfan M; Hussain R
    Clin Vaccine Immunol; 2009 Jul; 16(7):991-8. PubMed ID: 19439524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.
    Jason J; Archibald LK; Nwanyanwu OC; Kazembe PN; Chatt JA; Norton E; Dobbie H; Jarvis WR
    Infect Immun; 2002 Nov; 70(11):6188-95. PubMed ID: 12379697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytokine response to bacille Calmette Guérin vaccination in South India.
    Das SD; Narayanan PR; Kolappan C; Colston MJ
    Int J Tuberc Lung Dis; 1998 Oct; 2(10):836-43. PubMed ID: 9783532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.